Ascendis Pharma (ASND) PT Lowered to $330 at Jefferies

August 31, 2026 8:51 AM

Jefferies analyst Kelly Shi lowered the price target on Ascendis Pharma (NASDAQ: ASND) to $330.00 (from $333.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found